Stay updated on prGCD in Gaucher Disease Clinical Trial

Sign up to get notified when there's something new on the prGCD in Gaucher Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the prGCD in Gaucher Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the treatment protocol for patients with Gaucher disease who require enzyme replacement therapy. This change may reflect an adjustment in the dose of plant cell expressed recombinant glucocerebrosidase (prGCD) being administered to eligible patients.
    Difference
    0.1%
    Check dated 2024-06-06T14:41:00.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed participation criteria for the study, specifying eligibility requirements such as age, diagnosis, and consent, as well as exclusion criteria like current experimental drug use and certain allergies.
    Difference
    11%
    Check dated 2024-05-22T21:34:59.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:32:08.000Z thumbnail image

Stay in the know with updates to prGCD in Gaucher Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the prGCD in Gaucher Disease Clinical Trial page.